National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 5) (No. PB 50 of 2011)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
PB 50 of 2011
National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 5)1
National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.
Dated                 21 July                                 2011
 
 
 
 
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 5).
            (2)        This Instrument may also be cited as PB 50 of 2011.
2          Commencement
            This Instrument commences on 1 August 2011.        
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
 
[1]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”:                          5.91        substitute:             6.78
[2]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”:                          8.53        substitute:             8.78
[3]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin
(as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
omit from the column headed “Claimed Price”:                          4.10        substitute:             4.96
[4]       Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin
(as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
omit from the column headed “Claimed Price”:                          5.33        substitute:             6.20
[5]       Schedule 1, entry for Bromocriptine
omit:
 
Tablet 2.5 mg (as mesylate)
Oral
Parlodel
30
10.87
13.21

 
 
Oral
Parlodel
60
21.74
24.15

[6]       Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
(a) omit from the column headed “Determined Price”:               18.82     substitute:             12.71
(b) omit from the column headed “Claimed Price”:                    22.90     substitute:             15.46
[7]       Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
(a) omit from the column headed “Determined Price”:               18.93     substitute:             12.79
(b) omit from the column headed “Claimed Price”:                    24.89     substitute:             16.82
[8]       Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)
(a) omit from the column headed “Determined Price”:               5.53        substitute:             5.27
(b) omit from the column headed “Claimed Price”:                    9.65        substitute:             9.39
[9]       Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)
(a) omit from the column headed “Determined Price”:               7.89        substitute:             7.57
(b) omit from the column headed “Claimed Price”:                    12.03     substitute:             11.71
[10]     Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)
(a) omit from the column headed “Determined Price”:               14.16     substitute:             13.70
(b) omit from the column headed “Claimed Price”:                    18.30     substitute:             17.85
[11]     Schedule 1, entry for Lamotrigine in the form Tablet 5 mg
omit from the column headed “Claimed Price”:                          9.18        substitute:             10.57
[12]     Schedule 1, entry for Lamotrigine in the form Tablet 25 mg
omit from the column headed “Claimed Price”:                          19.63     substitute:             21.03
[13]     Schedule 1, entry for Lamotrigine in the form Tablet 50 mg
omit from the column headed “Claimed Price”:                          32.40     substitute:             34.00
[14]     Schedule 1, entry for Lamotrigine in the form Tablet 100 mg
omit from the column headed “Claimed Price”:                          53.42     substitute:             54.87
[15]     Schedule 1, entry for Lamotrigine in the form Tablet 200 mg
omit from the column headed “Claimed Price”:                          89.28     substitute:             90.74
[16]     Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
(a) omit from the column headed “Determined Price”:               8.07        substitute:             7.17
(b) omit from the column headed “Claimed Price”:                    10.94     substitute:             10.22
[17]     Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
(a) omit from the column headed “Determined Price”:               13.48     substitute:             11.99
(b) omit from the column headed “Claimed Price”:                    16.35     substitute:             15.04
[18]     Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
(a) omit from the column headed “Determined Price”:               10.96     substitute:             9.60
(b) omit from the column headed “Claimed Price”:                    12.09     substitute:             10.59
[19]     Schedule 1, entry for Meloxicam in the form Tablet 15 mg
(a) omit from the column headed “Determined Price”:               15.99     substitute:             14.01
(b) omit from the column headed “Claimed Price”:                    17.12     substitute:             15.00
[20]     Schedule 1, entry for Methylprednisolone
(a) omit from the column headed “Determined Price”:               15.49     substitute:             13.01
(b) omit from the column headed “Claimed Price”:                    16.11     substitute:             13.53
[21]     Schedule 1, entry for Nifedipine in the form Tablet 10 mg
(a) omit from the column headed “Determined Price”:               7.80        substitute:             7.46
(b) omit from the column headed “Claimed Price”:                    8.77        substitute:             8.43
[22]     Schedule 1, entry for Nifedipine in the form Tablet 20 mg
(a) omit from the column headed “Determined Price”:               9.71        substitute:             9.18
(b) omit from the column headed “Claimed Price”:                    11.53     substitute:             11.00
[23]     Schedule 1, entry for Nifedipine in the form Tablet 20 mg (controlled release)
(a) omit from the column headed “Determined Price”:               9.68        substitute:             9.56
(b) omit from the column headed “Claimed Price”:                    11.55     substitute:             11.43
[24]     Schedule 1, entry for Nifedipine in the form Tablet 30 mg (controlled release)
(a) omit from the column headed “Determined Price”:               10.45     substitute:             10.32
(b) omit from the column headed “Claimed Price”:                    12.55     substitute:             12.42
[25]     Schedule 1, entry for Nifedipine in the form Tablet 60 mg (controlled release)
(a) omit from the column headed “Determined Price”:               13.13     substitute:             12.97
(b) omit from the column headed “Claimed Price”:                    15.45     substitute:             15.29
[26]     Schedule 1, entry for Ranitidine in the form Tablet 150 mg (as hydrochloride)
omit from the column headed “Claimed Price”:                          10.98     substitute:             11.50
[27]     Schedule 1, entry for Ranitidine in the form Tablet 300 mg (as hydrochloride)
omit from the column headed “Claimed Price”:                          10.98     substitute:             11.50
[28]     Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses
(CFC-free formulation)
(a) omit from the column headed “Determined Price”:               3.83        substitute:             3.22
(b) omit from the column headed “Claimed Price”:                    4.50        substitute:             3.78
[29]     Schedule 1, after entry for Sulfasalazine
insert in the columns in the order indicated:
Sumatriptan
Tablet 50 mg (as succinate)
Oral
Imigran
2
7.81
8.61
[30]     Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
omit from the column headed “Claimed Price”:                          4.27        substitute:             4.36
[31]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
omit from the column headed “Claimed Price”:                          9.87        substitute:             10.07
[32]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
omit from the column headed “Claimed Price”:                          12.72     substitute:             12.95
[33]     Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
omit from the column headed “Claimed Price”:                          15.11     substitute:             15.38
[34]     Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
(a) omit from the column headed “Determined Price”:               11.23     substitute:             10.22
(b) omit from the column headed “Claimed Price”:                    11.84     substitute:             10.78
[35]     Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
(a) omit from the column headed “Determined Price”:               22.24     substitute:             20.23
(b) omit from the column headed “Claimed Price”:                    22.90     substitute:             20.83
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.

Related Laws